A recent study in a murine model of melanoma showed that tissue resident CD103+ DCs are needed for the generation of anti-tumor effector T cell responses through TAA delivery to tumor-draining lymph nodes during PD-L1 blockade [172]. The gene discussed is CD274; the disease is neoplasm.